Only Lyme disease vaccine under development goes into phase 3 trials
CNN — Vaccine maker Pfizer says it has begun a Phase 3 clinical trial of its Lyme disease vaccine candidate with French vaccine company Valneva SE. The biotech companies are recruiting about 6,000 participants ages 5 and older at up to 50 locations in areas of Europe and the US where Lyme disease is endemic, … Read more